How does Merilog (insulin aspart-szjj) work in your body? A plain-English explanation of its mechanism of action, how fast it works, and how it compares to other insulins.
Merilog (Insulin Aspart-szjj) is a rapid-acting insulin that works by mimicking the burst of insulin your pancreas would normally release when you eat a meal — helping your body move sugar from your blood into your cells where it's used for energy.
That's the short version. If you want to understand why Merilog works the way it does, how it behaves in your body, and what makes it different from other insulins, here's the plain-English breakdown.
To understand Merilog, it helps to understand what insulin does naturally.
When you eat, your digestive system breaks food down into glucose (sugar), which enters your bloodstream. Your pancreas detects this rise in blood sugar and releases insulin — a hormone that acts like a key, unlocking the doors on your cells so glucose can enter. Without that key, sugar piles up in your blood while your cells starve for energy. That's diabetes in a nutshell.
In type 1 diabetes, the pancreas doesn't make insulin at all. In type 2 diabetes, the body either doesn't make enough insulin or doesn't respond to it properly (insulin resistance). Either way, blood sugar stays too high.
Merilog steps in as a replacement for that mealtime insulin burst. Here's what it does once injected:
Merilog's active ingredient is Insulin Aspart — a human insulin analog that's almost identical to the insulin your body makes naturally. The difference? One tiny tweak: a single amino acid at position B28 is swapped from proline to aspartic acid.
This small molecular change has a big practical effect. Normal human insulin molecules tend to clump together (forming hexamers) when injected under the skin, and it takes time for those clumps to break apart before the insulin can be absorbed into your bloodstream. The aspartic acid substitution in Insulin Aspart prevents this clumping, which means the insulin absorbs faster after injection.
That's why Merilog is classified as a "rapid-acting" insulin — it gets to work quickly after you inject it, matching the timing of the blood sugar spike from your meal.
Here's the typical timeline after a subcutaneous injection:
This is why you inject Merilog 5-10 minutes before eating — it gives the insulin a head start so it's active by the time food hits your bloodstream. If you inject too early, you risk low blood sugar before the meal. Too late, and your blood sugar spikes before the insulin catches up.
Merilog's blood sugar-lowering effect typically lasts 3-5 hours, which covers the time it takes your body to digest and absorb a meal. After that, your basal (long-acting) insulin takes over to manage blood sugar between meals and overnight.
Most people on Merilog take it with each meal (2-3 times per day) in addition to a once-daily or twice-daily basal insulin like Lantus (Insulin Glargine), Basaglar, or Toujeo. This combination is called a basal-bolus regimen, and it's designed to mimic the natural pattern of insulin release — a steady baseline plus bursts at mealtimes.
Merilog isn't the only rapid-acting insulin out there. Here's how it compares:
Merilog is a biosimilar to NovoLog — same active ingredient, same mechanism, same clinical performance. The main difference is the manufacturer (Sanofi vs. Novo Nordisk) and price. Merilog is available for $35/month through Sanofi's Valyou Savings Program.
Humalog uses a different insulin analog (Insulin Lispro instead of Insulin Aspart), but both are rapid-acting with very similar onset, peak, and duration profiles. The choice between them often comes down to insurance coverage, cost, and personal preference. Both are effective mealtime insulins.
Fiasp is an ultra-rapid formulation of Insulin Aspart that contains added niacinamide to speed up absorption even further. Fiasp starts working slightly faster than standard Insulin Aspart products like Merilog and NovoLog. However, Fiasp has been experiencing supply shortages, making Merilog a more reliable option in 2026.
Apidra uses yet another insulin analog (Insulin Glulisine) with a slightly different molecular structure. Its onset and duration are comparable to Merilog. Both are made by Sanofi.
For a full comparison of alternatives, check out our Merilog alternatives guide.
Knowing how your insulin works helps you use it more effectively:
Merilog works by doing what your pancreas can't — delivering a rapid burst of insulin at mealtimes to move sugar out of your blood and into your cells. Its slightly modified molecular structure means it absorbs faster than regular insulin, making it ideal for covering the blood sugar rise that comes with eating.
Understanding how Merilog works empowers you to use it more effectively and have better conversations with your healthcare team about your diabetes management. If you'd like to learn more about the medication, read our complete guide to Merilog, or learn about potential side effects.
Need Merilog? Search Medfinder to find it in stock at a pharmacy near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
